Kakao Healthcare ties up with Dexcom for global diabetes biz

South Korea’s Kakao Healthcare Corp. has taken a step forward to expand its business into the global market by collaborating with US medical d...

Celltrion puts Takeda’s assets up for sale after 3 years

South Korea’s Celltrion Inc. has put its Japanese Takeda Pharmaceutical Co.'s primary care assets acquired in 2020 on sale as the biosimilar g...

SK Biopharm’s Cenobamate gets nod in Canada, to boost US sales

South Korea’s SK Biopharmaceuticals Co. has obtained the sales approval for its antiepileptic treatment Cenobamate in Canada, paving the way f...

Celltrion wins phase 3 IND approval for Ocrevus biosimilar in US

South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...

Celltrion to expand biosimilar portfolio to 11 by 2025

South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...

S.Korea to seek expansion of healthcare package export

South Korean government has set a goal to expand medical service exports by attracting 700,000 foreign patients and receiving 70 applications of ove...

Bredis Healthcare, Tilda win June D.Day, Korea’s oldest startup pitch race

An early-stage startup by young entrepreneurs who developed a digital diagnostic tool for brain disease and an AI-powered business optimization prog...

Celltrion to develop Humira biosimilar oral medication with US firm

South Korea's biopharmaceutical company Celltrion Inc. announced on Monday that it has signed a contract with the US biotech firm Rani Therapeutics ...

Celltrion’s Remsima SC praised in Europe as preferred biosimilar

MILAN – South Korea's biopharmaceutical company Celltrion Inc. is known in Europe for its biosimilar products such as autoimmune disease treat...

Celltrion unveils phase 1 clinical data of Actemra biosimilar in Europe

South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...

BIO USA 2023 to draw S.Korean biotech leaders, startups

More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...

Celltrion gets FDA approval for Humira biosimilar CT-P17

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...

CrystalGenomics to sell largest 20% stake to Invites Healthcare for $44 mn

CrystalGenomics Inc., South Korea’s first-generation biopharma venture company, will sell new shares worth 58 billion won ($44 million) in a b...

Celltrion Healthcare launches Remsima SC in Brazil

South Korean biopharmaceutical company Celltrion Healthcare Co. revealed on Monday its introduction of Remsima SC, a treatment for autoimmune diseas...

KT to open medical checkup center in Hanoi, Vietnam

South Korea's KT Corp. next year will launch a medical checkup center in Hanoi, Vietnam, under a strategy to advance its digital healthcare business...

Celltrion drops bid to acquire Baxter’s biopharm unit

Celltrion Inc. announced on Tuesday it has decided not to pursue the acquisition of the biopharmaceutical unit of U.S. medical device maker Baxter I...

S.Korean startups eye on Southeast Asia as promising market

SINGAPORE - Southeast Asia with a youth population constituting about one-third of the region’s total population and surging internet penetrat...

Defense, healthcare lure global funds in dull market

Defense, healthcare and semiconductor materials companies have been the main investment targets of global funds such as Fidelity and Morgan Stanley ...

Celltrion applies for Phase 3 clinical trials in Europe for biosimilar

South Korea’s Celltrion Inc. is speeding up global clinical trials of its biosimilar of the multiple sclerosis (MS) treatment Ocrevus (active ...

Kakao Healthcare teams up with US digital, biohealth firms

Kakao Healthcare, a digital healthcare platform unit of South Korea's Kakao Group, has teamed up with US digital and health companies such as DexCom...

S.Korean walking app Cashwalk debuts in Spain, Italy

Nudge Healthcare, a South Korean startup that operates the health management app Cashwalk, has added Italy and Spain to the list of overseas markets...

S.Korea gov’t hosts sales event for domestic, US SMEs

South Korean small- and medium-sized enterprises (SMEs) expanded their exchange and cooperation with US firms during President Yoon Suk yeol's state...

More Korean LPs look to buyouts, special situations for private equity

Healthcare continued to be the preferred sector for South Korean institutional investors this year as it was last year, a survey found. Meanwhile, the...

Celltrion Healthcare enters top 10 in hospital prescriptions in Turkey

South Korean biopharmaceutical company Celltrion Healthcare Co. on Thursday said it ranked in the top 10 out of 400 companies last year on the Turki...

Samsung unveils HealthStack at US healthcare tech exhibition

Samsung Electronics Co. announced on Tuesday that it will showcase Samsung HealthStack ver. 1.0 at the "2023 HIMSS Global Health Conference & Ex...

MBK Partners co-founder tops 50 richest S.Koreans: Forbes

Michael ByungJu Kim, co-founder and partner at private equity firm MBK Partners, has topped the ranking of the 50 richest South Koreans by net worth...

S.Korea's Celltrion Healthcare launches Vegzelma in US

South Korea's Celltrion Healthcare Co. on Monday said it launched on the US market Vegzelma, a biosimilar of Bevacizumab, a medication for colorecta...

Famed S.Korean pedometer app Cashwalk attracts first investment of $22 million

Nudge Healthcare, a startup that runs the South Korean health management app Cashwork, on Wednesday said it secured its first investment of 30 billi...

LG to unveil healthcare product; open to startup M&As

South Korea’s LG Electronics Inc. is set to unveil its first digital healthcare product in the second half of this year, three years after it ...

Biosimilar giant Celltrion to transform into drug developer

South Korean biosimilar giant Celltrion Group aims to transform into a drug developer by generating 40% of sales from new medicines by 2030 as it is...